CellCarta is a global contract research organization providing testing services including biomarker solutions, immune monitoring, proteomics, genomics, histopathology, and regulatory expertise. This description is self-described as the company offers advanced scientific capabilities to support therapeutic development.

CellCarta

CellCarta | 24,476 followers on LinkedIn. As a global leader in precision medicine testing services, we partner with our clients to address the most complex biomarker and bioanalytical challenges and deliver highly customized testing solutions. With facilities located in Canada, United States, Belgium, Australia and China, CellCarta provides the expertise needed locally to support global clinical trials. 

CellCarta offers access to integrated analytical platforms in immunology (immune monitoring), histopathology, proteomics and genomics, as well as digital pathology/AI and sample management, logistics and kitting services.

Mark Watson

Senior Financial Analyst

Anna-Maria Leoci

Co-founder and Vice-Chairman at CellCarta

Martin LeBlanc

Christopher Ung

⭐ Live from #SITC2024 ! Catch Elizabeth Ross and Mark Kockx presenting poster #126 on developing a visual scoring method to determine inflamed, excluded or desert immune phenotype in NSCLC, colorectal, and urothelial cancers. Missed yesterday’s posters. No worries, Damien Montamat-Sicotte and Jean-Philippe Goulet are still at Booth 1310, ready to chat about cytometry analysis (#833) and advanced CITE-seq data (#163). Stop by to connect. #PrecisionMedicine #Immunooncology #Biomarkers

Think you’ve got what it takes to top the leaderboard? 🎮 Swing by Booth #1310 and prove it! Ready, set, game on! 💥 See you there!

Hello from the team at #SITC2024 ! 👋 We’d love to chat about your latest scientific challenges and how we can support your immunotherapy research. Drop by Booth 1310 or book a meeting here 👇 https://bit.ly/3HQzLHL See you there!

Can you clear the competition at #SITC2024 ? Put your gaming skills to the test, visit Booth 1310! 🕹️

Today is #InternationalPathologyDay ! 🔬 Let’s take a moment to recognize the skilled pathologists working tirelessly to guide treatments, and advance research. At CellCarta, we really don’t know where we’d be without our own talented team of pathologists. Meet the team here 👉 https://lnkd.in/g-sQqaT8

#SITC2024 is starting tomorrow! Don’t miss our three posters: ⭐ Abstract 126: Development of a visual scoring method to determine inflamed, excluded or desert immune phenotype in non-small cell lung cancer, colorectal cancer, and urothelial cancer ⭐ Abstract 833: Accelerating analysis of cytometry data sets leveraging a visualization tool built within CellEngine, a cloud-based cytometry analysis software ⭐ Abstract 163: Analyzing CITE-seq data like an immunologist with a hybrid hierarchical gating approach in CellEngine software Stop by the posters and book a meeting with our team to find out more! https://bit.ly/3HQzLHL #PrecisionMedicine #Immunooncology #Biomarkers Show Less

Did you know CellCarta offers kitting solutions to facilitate the logistics of PK and biomarker samples during clinical trials? Our team of experts collaborates with you to ensure kits are tailored to your needs. Check out our services: https://bit.ly/3YRjyJN #CellCarta #CROLaboratory #Precisionmedicine

Our Naperville laboratory is upgrading its genomic capabilities with the NovaSeq X Plus sequencing instrument. This exciting development means we are now able to provide our customers with: ✔️Faster sequencing times ✔️Increased throughout ✔️Improved cost efficiency We are delighted to bring these benefits to you, and to continue to utilize the latest innovations in sequencing to support your research. Learn more: https://bit.ly/3URAuzt #Genomics #PrecisionMedicine #PCR #CellCarta

PBMC processing following robust, standardized SOPs to ensure quality data. Sounds interesting? https://bit.ly/4foNlll Our state-of-the-art facility in Naperville, U.S. offers PBMC processing and delivers: ⭐ Fast turn arounds to support short stability windows, with samples collected, shipped and processed within 24hrs ⭐ Capabilities with both Ficoll and CPT tubes that lead to >90% cell viability ⭐ Onsite biorepository services Discover why we’re the CRO partner of choice for PBMC processing, but also sample logistics the world over. 🌏 https://bit.ly/4cSIvuL #CellCarta #PrecisionMedicine #CellTherapy

Unsure how to transition your clinical trial assay to companion diagnostic (CDx)? Our experts can help. Learn more here 👉 https://bit.ly/3qALZ2d #CellCarta #ClinicalTrials #PrecisionMedicine

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 11, 2024 9:16 AM	c35aef95
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 11, 2024 9:16 AM	044cec7c
crunchbase trigger	general	Nov 11, 2024 9:16 AM	a857d20b
crunchbase profile	general
li profile	general	Nov 11, 2024 9:16 AM	a4023e9e
translate crunchbase fundingrounds	general
peers	general	Nov 11, 2024 9:16 AM	11d27517
news basic	general	Nov 11, 2024 9:16 AM	e34b9611
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

CELL

COM:CELLCARTA

CellCarta